Release Date: 22/03/12 15:49 Summary: Lodgement of Patent Price Sensitive: Yes Download Document 900.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%